To further clarify the involvement of DS in the activation of IFN-I signaling, we treated tumor cells with DS and observed a robust enhancement in IFN-β-Luc activity (Fig. 1D) in both HCT116 and MC38 cells, exhibiting a time- and dose-dependent response. Here, IFNB1 is linked to neoplasm.